NSPR

InspireMD, Inc. NSPR

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,634 of 2,925

Why it scores 25Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$1.77M

Quarter to Jun 30

Net income

$-14.32M

Quarter to Jun 30

Free cash flow

$-11.22M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$15.07M total
Rosalind Advisors, Inc.
$2.73M0.0%
abrdn plc
$2.59M+16.5%
Nantahala Capital Management, LLC
$2.36M0.0%
ORBIMED ADVISORS LLC
$2.19M0.0%
Parkman Healthcare Partners LLC
$1.69M0.0%
MARSHALL WACE, LLP
$1.30M0.0%
Soleus Capital Management, L.P.
$732.1K0.0%
PURA VIDA INVESTMENTS, LLC
$315.4K0.0%
INGALLS & SNYDER LLC
$258.0K-2.8%
Affiance Financial, LLC
$175.3K0.0%
Velan Capital Investment Management LP
$103.7K-92.9%
BlackRock, Inc.
$86.1K+52.9%
RENAISSANCE TECHNOLOGIES LLC
$79.0K+540.8%
Creative Planning
$76.3K+452.7%
Schonfeld Strategic Advisors LLC
$69.5KNew
HRT FINANCIAL LP
$41.0KNew
XTX Topco Ltd
$34.3K+296.7%
Centiva Capital, LP
$30.9K+78.2%
MILLENNIUM MANAGEMENT LLC
$26.4K-66.5%
COURIER CAPITAL LLC
$21.0K0.0%
Mesirow Financial Investment Management, Inc.
$21.0K0.0%
MORGAN STANLEY
$19.9K-28.8%
VESTIA PERSONAL WEALTH ADVISORS
$17.1K0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$14.4KNew
Cambridge Investment Research Advisors, Inc.
$14.0KNew
See all 37 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/NSPR

Earnings Per Share

13fpro.ai/company/NSPR

Loading ratio trend…

NSPR key financials by period

Reported revenue, net income and operating margin by fiscal year, from InspireMD, Inc.'s annual filings on SEC EDGAR.

InspireMD, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$9.0M$-48.8M—
FY 2024$7.0M$-32.0M—
FY 2023$6.2M$-19.9M—
FY 2022$5.2M$-18.5M—
FY 2021$4.5M$-14.9M—
FY 2020$2.5M$-10.5M—
Source: NSPR filings on SEC EDGAR →

NSPR insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About InspireMD, Inc. (NSPR): stock profile, AI score and financials

InspireMD, Inc. (NSPR) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NSPR at 25.2/100 on a composite quality score built from its SEC filings, placing it at rank #2,634 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), InspireMD, Inc. reports quarterly revenue of $1.8M, net income of $-14.3M, free cash flow of $-11.2M. Top institutional holders of NSPR by reported 13-F value include Rosalind Advisors, abrdn plc, Nantahala Capital Management, based on the most recent SEC filings. NSPR trades on the Nasdaq exchange and files with the SEC under CIK 1433607. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NSPR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for InspireMD, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1433607 →